Clinical Trials Logo
  1. Home
  2. Gout Flare
  3. NCT04069325

Efficacy and Safety of Simiaowan in Prevention of Acute Flares in Chronic Gout Patients Initiating Febuxostat Therapy

Gout Flare Clinical Trial

Official title:
Efficacy and Safety of Simiaowan in Prevention of Acute Flares in Chronic Gout Patients Initiating Febuxostat Therapy：a Randomized Controlled Trial

Clinical Trial Summary

The aim of this study is to evaluate the efficacy and safety of simiaowan in prevention of acute flares in chronic gout patients initiating febuxostat therapy.

Clinical Trial Description

The study is a multicenter, randomized, double-blind, placebo-controlled, 12-week trial. To determine whether oral simiaowan at standard clinical doses (6g twice daily), compared to placebo, can reduce the incidence of acute gout flares and decrease the serum uric acid level. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04069325
Study type Interventional
Source Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Contact Jiang Quan, Doctor
Phone 86-010-88001132
Email doctorjq@126.com
Status Not yet recruiting
Phase N/A
Start date September 1, 2019
Completion date July 28, 2020
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05522504 - Distribution of Immune Cells and Their Subtypes in Peripheral Blood of Gout
Terminated NCT03933007 - Relation Between Blood Concentration of Colchicine and Response to Colchicine Treatment in Gout Flare Phase 4
Recruiting NCT05586958 - Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients Phase 3
Active, not recruiting NCT06197828 - Novel Biomarkers for Early Renal Injury in Children With Sepsis
Recruiting NCT05586971 - Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients Phase 3
Not yet recruiting NCT04849312 - Prediction of 30-Day Readmission Using Machine Learning
Active, not recruiting NCT04784351 - Prediction of Expected Length of Hospital Stay Using Machine Learning
Active, not recruiting NCT05045742 - Prediction of Patient Deterioration Using Machine Learning
Completed NCT03203759 - Hospital-Level Care at Home for Acutely Ill Adults N/A
Recruiting NCT05936268 - Safety and Efficacy of Genakumab for Injection in Patients With Gout Flare Phase 2
Active, not recruiting NCT03621215 - The Effect of Tart Cherry Juice on Risk of Gout Attacks N/A
Recruiting NCT05658575 - Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare Phase 2/Phase 3
Recruiting NCT03524222 - Home Hospital for Suddenly Ill Adults N/A
Not yet recruiting NCT06273813 - Treatment of Topical Ketorolac Gel in Acute Gouty Flare Phase 1
Completed NCT04531280 - Rural Home Hospital: Proof of Concept N/A
Completed NCT05256303 - Rural Hospital-Level Care at Home for Acutely Ill Adults N/A
Not yet recruiting NCT06207045 - The Effects of Limb Elevation During Gout Flare Episodes N/A
Completed NCT04080570 - Remote Physician Care for Home Hospital Patients N/A